NCT06039306 Perioperative Immunonutrition Under Enhanced Recovery After Surgery
| NCT ID | NCT06039306 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universiti Putra Malaysia |
| Condition | Gynecological Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 106 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2025-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 106 participants in total. It began in 2024-09-01 with a primary completion date of 2025-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the effect of perioperative immunonutrition supplement in gynecologic cancer patients. The main questions it aims to answer are: * is there any difference in the nutritional outcomes and functional outcomes between intervention and conventional groups? * is there any difference in the post-surgical outcomes between intervention and conventional groups? Participants (intervention) will be provided the immunonutrition supplement before and after operation. Researchers will compare intervention group with conventional group to see if there is any difference in postoperative outcomes.
Eligibility Criteria
Inclusion Criteria: 1. Those who diagnosed with GC 2. Candidates for elective operation treatments Exclusion Criteria: 1. Those are involved gastrointestinal tract (complication) 2. Those are diagnosed with GC (metastasis) 3. Allergy to milk/soy/whey protein 4. Participate in other intervention study
Contact & Investigator
ChiouYi Ho
PRINCIPAL INVESTIGATOR
National Cancer Institute, Malaysia
Frequently Asked Questions
Who can join the NCT06039306 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 80 Years, studying Gynecological Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06039306 currently recruiting?
Yes, NCT06039306 is actively recruiting participants. Contact the research team at agneshcy0326@gmail.com for enrollment information.
Where is the NCT06039306 trial being conducted?
This trial is being conducted at Putrajaya, Malaysia.
Who is sponsoring the NCT06039306 clinical trial?
NCT06039306 is sponsored by Universiti Putra Malaysia. The principal investigator is ChiouYi Ho at National Cancer Institute, Malaysia. The trial plans to enroll 106 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.